These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 14978513)

  • 41. Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients.
    Kiliç C; Curran HV; Noshirvani H; Marks IM; Başoğlu M
    Psychol Med; 1999 Jan; 29(1):225-31. PubMed ID: 10077311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
    Klein E; Uhde TW; Post RM
    Am J Psychiatry; 1986 Feb; 143(2):235-6. PubMed ID: 2868666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growing placebo response rate: the problem in recent therapeutic trials?
    Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
    Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 46. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder.
    Roy-Byrne P; Russo J; Pollack M; Stewart R; Bystrisky A; Bell J; Rosenbaum J; Corrigan MH; Stolk J; Rush AJ; Ballenger J
    Psychol Med; 2003 Apr; 33(3):511-8. PubMed ID: 12701671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alprazolam extended-release in panic disorder.
    Rickels K
    Expert Opin Pharmacother; 2004 Jul; 5(7):1599-611. PubMed ID: 15212610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressants versus placebo for panic disorder in adults.
    Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G; Annable L; Fontaine R; Solyom L
    Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Chouinard G; Labonte A; Fontaine R; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Ballenger JC
    J Psychiatr Res; 1990; 24 Suppl 2():15-25. PubMed ID: 1980694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC; Fogari R
    J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Klein E; Zinder O; Colin V; Zilberman I; Levy N; Greenberg A; Lenox RH
    Acta Psychiatr Scand; 1995 Dec; 92(6):399-408. PubMed ID: 8837965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
    Fukuda M; Takazawa S; Nakagome K; Iwanami A; Hata A; Kasai K; Hiramatsu K
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.